LeonaBio, Inc. (LONA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $69.28M | +43.0% |
| 2024 | $48.44M | -46.5% |
| 2023 | $90.58M | -5.6% |
| 2022 | $95.97M | -13.2% |
| 2021 | $110.54M | +82.3% |
| 2020 | $60.62M | +2848.7% |
| 2019 | $2.06M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $69.28M | +43.0% |
| 2024 | $48.44M | -46.5% |
| 2023 | $90.58M | -5.6% |
| 2022 | $95.97M | -13.2% |
| 2021 | $110.54M | +82.3% |
| 2020 | $60.62M | +2848.7% |
| 2019 | $2.06M | — |